Table 8 Characteristics of the malarial VL co-infected patients versus the non-malarial VL patients enrolled in the MSF’s clinical trial at Um-el-Kher and Kassab Hospitals, Sudan (1998)
Variable | Cases n(%) | Controls n(%) | Crude Odds Ratio | 95% Confidence Interval |
|---|---|---|---|---|
Age | 89 | 427 | ||
Median (years), (interquartile range) | 7 (4-14) | 10 (6-17) | ||
Treatment center | 89 | 427 | ||
Kassab Hospital | 17 (19.1) | 134 (31.4) | 1 | |
Um-el-Kher Hospital | 72 (80.9) | 293 (68.6) | 1.94 | 1.10-3.41* |
Fatal outcome | 89 | 427 | ||
No | 79 (88.8) | 415 (97.2) | 1 | |
Yes | 10 (11.2) | 12 (2.8) | 4.38 | 1.83-10.48* |
Hb level | 89 | 427 | ||
Median (g/dl), (interquartile range) | 7.5 (6.0-9.0) | 8.2 (7.0-9.4) | ||
≥5.3 g/dl | 75 (84.3) | 405 (94.8) | 1 | |
<5.3 g/dl | 14 (15.7) | 22 (5.2) | 3.44 | 1.68-7.02* |
Nutritional status | 68 | 299 | ||
Mean Weigh for Height (%) | 78.8 | 80.4 | ||
Weight for Height Percent ≥70% | 60 (88.2) | 279 (93.3) | 1 | |
Weight for Height Percent <70% | 8 (11.8) | 20 (6.7) | 1.86 | 0.78-4.42 |
Spleen size below the costal margin | 80 | 389 | ||
Median (cm), (interquartile range) | 6 (3-8) | 7 (4-10) | ||
<6 cm | 33 (41.2) | 144 (37.0) | 1 | |
≥6 cm | 47 (58.8) | 245 (63.0) | 0.84 | 0.51-1.37 |
Duration on-going sickness | 86 | 422 | ||
Median (days), (interquartile range) | 30 (15-60) | 30 (20-60) | ||
<60 days | 62 (72.1) | 286 (67.8) | 1 | |
≥60 days | 24 (27.9) | 136 (32.2) | 0.81 | 0.49-1.36 |